Impact of Hepatitis C Virus Co-infection on Antiretroviral Therapy Outcomes in Adults Living with HIV - China, 2002-2023.

IF 2.9 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Decai Zhao, Jingkun Hu, Yan Zhao, Xiumin Gan, Fan Lyu
{"title":"Impact of Hepatitis C Virus Co-infection on Antiretroviral Therapy Outcomes in Adults Living with HIV - China, 2002-2023.","authors":"Decai Zhao, Jingkun Hu, Yan Zhao, Xiumin Gan, Fan Lyu","doi":"10.46234/ccdcw2026.016","DOIUrl":null,"url":null,"abstract":"<p><strong>What is already known about this topic?: </strong>The impact of hepatitis C virus (HCV) co-infection on antiretroviral therapy (ART) outcomes in people living with human immunodeficiency virus (HIV) remains controversial across studies.</p><p><strong>What is added by this report?: </strong>Using stratified matching methods, we constructed two cohorts - one with HIV/HCV co-infection and one with HIV mono-infection - to compare ART outcomes. Our analysis revealed that HIV/HCV co-infected individuals faced significantly elevated risks of mortality, virological failure, and attrition relative to their HIV mono-infected counterparts.</p><p><strong>What are the implications for public health practice?: </strong>Enhanced prevention, screening, and management (including treatment) of hepatitis C virus within people living with human immunodeficiency virus should be prioritized and strengthened as part of routine clinical care.</p>","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"8 4","pages":"87-91"},"PeriodicalIF":2.9000,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12983037/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国疾病预防控制中心周报","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.46234/ccdcw2026.016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

What is already known about this topic?: The impact of hepatitis C virus (HCV) co-infection on antiretroviral therapy (ART) outcomes in people living with human immunodeficiency virus (HIV) remains controversial across studies.

What is added by this report?: Using stratified matching methods, we constructed two cohorts - one with HIV/HCV co-infection and one with HIV mono-infection - to compare ART outcomes. Our analysis revealed that HIV/HCV co-infected individuals faced significantly elevated risks of mortality, virological failure, and attrition relative to their HIV mono-infected counterparts.

What are the implications for public health practice?: Enhanced prevention, screening, and management (including treatment) of hepatitis C virus within people living with human immunodeficiency virus should be prioritized and strengthened as part of routine clinical care.

丙型肝炎病毒合并感染对成人HIV感染者抗逆转录病毒治疗结果的影响——中国,2002-2023。
关于这个话题我们已经知道了什么?丙型肝炎病毒(HCV)合并感染对人类免疫缺陷病毒(HIV)感染者抗逆转录病毒治疗(ART)结果的影响在研究中仍存在争议。这份报告增加了什么内容?使用分层匹配方法,我们构建了两个队列,一个是HIV/HCV合并感染,另一个是HIV单一感染,以比较ART的结果。我们的分析显示,HIV/HCV合并感染个体的死亡率、病毒学失败和耗损风险明显高于单独感染HIV的个体。这对公共卫生实践有什么影响?应优先考虑并加强人类免疫缺陷病毒感染者体内丙型肝炎病毒的预防、筛查和管理(包括治疗),将其作为常规临床护理的一部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.90
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书